Literature DB >> 29358344

Standardized Definition of Structural Valve Degeneration for Surgical and Transcatheter Bioprosthetic Aortic Valves.

Danny Dvir1, Thierry Bourguignon2, Catherine M Otto1, Rebecca T Hahn3, Raphael Rosenhek4, John G Webb5, Hendrik Treede6, Maurice E Sarano7, Ted Feldman8, Harindra C Wijeysundera9, Yan Topilsky10, Michel Aupart2, Michael J Reardon11, G Burkhard Mackensen1, Wilson Y Szeto12, Ran Kornowski13, James S Gammie14, Ajit P Yoganathan15, Yaron Arbel10, Michael A Borger3, Matheus Simonato5, Mark Reisman1, Raj R Makkar16, Alexandre Abizaid17, James M McCabe1, Gry Dahle18, Gabriel S Aldea1, Jonathon Leipsic5, Philippe Pibarot19, Neil E Moat20, Michael J Mack21, A Pieter Kappetein22, Martin B Leon3.   

Abstract

Bioprostheses are prone to structural valve degeneration, resulting in limited long-term durability. A significant challenge when comparing the durability of different types of bioprostheses is the lack of a standardized terminology for the definition of a degenerated valve. This issue becomes especially important when we try to compare the degeneration rate of surgically inserted and transcatheter bioprosthetic valves. This document, by the VIVID (Valve-in-Valve International Data), proposes practical and standardized definitions of valve degeneration and provides recommendations for the timing of clinical and imaging follow-up assessments accordingly. Its goal is to improve the quality of research and clinical care for patients with deteriorated bioprostheses by providing objective and strict criteria that can be utilized in future clinical trials. We hope that the adoption of these criteria by both the cardiological and surgical communities will lead to improved comparability and interpretation of durability analyses.
© 2018 American Heart Association, Inc.

Entities:  

Keywords:  durability; echocardiographic criteria; reintervention; reoperation; transcatheter; valve deterioration

Mesh:

Year:  2018        PMID: 29358344     DOI: 10.1161/CIRCULATIONAHA.117.030729

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  52 in total

Review 1.  Valve durability after transcatheter aortic valve implantation.

Authors:  Akash Kataruka; Catherine M Otto
Journal:  J Thorac Dis       Date:  2018-11       Impact factor: 2.895

2.  Right anterior mini-thoracotomy and sutureless valves: the perfect marriage.

Authors:  Marco Solinas; Giacomo Bianchi; Francesca Chiaramonti; Rafik Margaryan; Enkel Kallushi; Tommaso Gasbarri; Filippo Santarelli; Michele Murzi; Pierandrea Farneti; Alessandro Leone; Simone Simeoni; Egidio Varone; Federica Marchi; Mattia Glauber; Giovanni Concistrè
Journal:  Ann Cardiothorac Surg       Date:  2020-07

3.  Bioprosthetic valve dysfunction and failure after TAVI in bicuspid aortic valve stenosis during one-year follow-up according to VARC-3.

Authors:  Ole de Backer; Tobias Zeus; Verena Veulemans; Philippe Nuyens; Shouheng Goh; Oliver Maier; Stephan Binnebößel; Jacqueline Heermann; Christian Jung; Ralf Westenfeld; Malte Kelm
Journal:  Clin Res Cardiol       Date:  2022-06-29       Impact factor: 5.460

4.  Stent and leaflet stresses across generations of balloon-expandable transcatheter aortic valves.

Authors:  Yue Xuan; Danny Dvir; Zhongjie Wang; Jian Ye; Julius M Guccione; Liang Ge; Elaine E Tseng
Journal:  Interact Cardiovasc Thorac Surg       Date:  2020-06-01

Review 5.  Mechanical considerations for polymeric heart valve development: Biomechanics, materials, design and manufacturing.

Authors:  Richard L Li; Jonathan Russ; Costas Paschalides; Giovanni Ferrari; Haim Waisman; Jeffrey W Kysar; David Kalfa
Journal:  Biomaterials       Date:  2019-09-17       Impact factor: 12.479

6.  Bacterial infiltration and bioprosthetic valve failure: Emerging diagnostics for emerging therapies.

Authors:  Alexander P Kossar; Isaac George; Rachel Gordon; Giovanni Ferrari
Journal:  J Thorac Cardiovasc Surg       Date:  2019-10-25       Impact factor: 5.209

7.  Model studies of advanced glycation end product modification of heterograft biomaterials: The effects of in vitro glucose, glyoxal, and serum albumin on collagen structure and mechanical properties.

Authors:  Christopher A Rock; Samuel Keeney; Andrey Zakharchenko; Hajime Takano; David A Spiegel; Abba M Krieger; Giovanni Ferrari; Robert J Levy
Journal:  Acta Biomater       Date:  2021-01-11       Impact factor: 8.947

8.  Long-term survival after Carpentier-Edwards Perimount aortic valve replacement in Western Denmark: a multi-centre observational study.

Authors:  Lytfi Krasniqi; Mads P Kronby; Lars P S Riber
Journal:  J Cardiothorac Surg       Date:  2021-05-14       Impact factor: 1.637

9.  Structural valve deterioration after aortic valve replacement with the Trifecta valve.

Authors:  Paul Werner; Jasmin Gritsch; Sabine Scherzer; Christoph Gross; Marco Russo; Iuliana Coti; Alfred Kocher; Guenther Laufer; Martin Andreas
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-01-01

10.  A valve-in-valve approach to manage severe bioprosthetic tricuspid valve stenosis.

Authors:  Dominika M Zoltowska; Naji Maaliki; Bashar Al-Turk; Andres M Pineda Maldonado; Srinivasan Sattiraju
Journal:  J Geriatr Cardiol       Date:  2021-05-28       Impact factor: 3.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.